GDF15 and atrial fibrillation: In ENGAGE AF-TIMI 48 trial, GDF-15 levels elevating from the baseline of 1661 pg/mL to 12 months of 1711 pg/mL were independently associated with a twofold higher rate of stroke or systemic embolic events in AF patients [27].